首页> 美国政府科技报告 >Preparation of a Hepatitis-Free Fibrinogen for Human Use Production in Animals of the Antibody to HAA Variants and Evaluation of Safety of Heat-Treated Antigen,
【24h】

Preparation of a Hepatitis-Free Fibrinogen for Human Use Production in Animals of the Antibody to HAA Variants and Evaluation of Safety of Heat-Treated Antigen,

机译:用于人类的无肝纤维蛋白原的制备用于Haa变体抗体的动物生产和热处理抗原的安全性评估,

获取原文

摘要

HBAb has been produced in guinea pigs,rabbits,horses,sheep,goats and chimpanzees using a partially purified antigen prepared by (PEG) fractionation. In nonprimates adsorption was performed using PEG at a concentration which precipitated complex but not HBAb or HBAg. PEG can also be used to enhance many immune-precipitant reactions. Immunologically active IgG was found to be present on HBAg prepared by several different methods and tagged with 125I. This provides an explanation for divergent radioimmune assay (RIA) results reported by various laboratories and suggests a mechanism for immune-tolerance in the carrier state. In a double antibody RIA,the first antibody should be non-primate so that the second antibody does not directly precipitate HBAg. A prototype for automatic plasma fractionation has been designed,constructed and proved satisfactory in initial testing. It appears well adapted to specialized fractionation procedures particularly those for obtaining coagulation factors,fibrinogen,Factor VIII and Factor IX,in high yield.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号